Showing results (181-190 of 210) with videos related to

Sort By:
Pageof 21
Brain Communications|February 10, 2025
The inflammatory APRIL (a proliferation-inducing ligand) antagonizes chondroitin sulphate proteoglycans to promote axonal growth and myelinationMashal Claude Ahmed, Tejaswini Kakunuri, Leticia Peris, et al.
The Journal of Clinical Investigation|January 10, 2002
Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndromeJoanna Groom, Susan L Kalled, Anne H Cutler, et al.
Nature Chemical Biology|December 24, 2005
C3-symmetric peptide scaffolds are functional mimetics of trimeric CD40LSylvie Fournel, Sébastien Wieckowski, Weimin Sun, et al.
The Journal of Biological Chemistry|May 9, 2015
Stoichiometry of Heteromeric BAFF and APRIL Cytokines Dictates Their Receptor Binding and Signaling PropertiesSonia Schuepbach-Mallepell, Dolon Das, Laure Willen, et al.
The Journal of Cell Biology|July 9, 2008
TWEAK-FN14 signaling induces lysosomal degradation of a cIAP1-TRAF2 complex to sensitize tumor cells to TNFalphaJames E Vince, Diep Chau, Bernard Callus, et al.
Journal of Neuroinflammation|October 1, 2017
αVβ3 Integrin regulates astrocyte reactivityRaúl Lagos-Cabré, Alvaro Alvarez, Milene Kong, et al.
The Journal of Experimental Medicine|April 16, 2008
TL1A-DR3 interaction regulates Th17 cell function and Th17-mediated autoimmune diseaseBhanu P Pappu, Anna Borodovsky, Timothy S Zheng, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 4, 2018
Identification of a new subset of lymph node stromal cells involved in regulating plasma cell homeostasisHsin-Ying Huang, Ana Rivas-Caicedo, François Renevey, et al.
Mabs|June 24, 2011
Development of an Fn14 agonistic antibody as an anti-tumor agentJennifer S Michaelson, Aldo Amatucci, Rebecca Kelly, et al.
Pageof 21